Cancer cells can treat tumors.
New scrutiny suggests that many cancer cells are equipped with a generous of suicide pill: a protein on their surfaces that gives them the gift to discharge an "eat me" outstanding to immune cells. The contest now, the researchers say, is to conspicuous out how to coax cancer cells into emitting the communicate rather than a dangerous "don't eat me" signal tretinoin pharmacy. A swot published online Dec 22 2010 in Science Translational Medicine reports that the cells propel out the enticing "eat me" wink by displaying the protein calreticulin.
But another molecule, called CD47, allows most cancer cells to elude rack and ruin by sending the antithetical signal: "Don't feed-bag me". In earlier research, Stanford University School of Medicine scientists found that an antibody that blocks CD47 - turning off the wave - could assistance scrimmage cancer, but mysteries remained. "Many general cells in the body have CD47, and yet those cells are not distressed by the anti-CD47 antibody," Mark Chao, a Stanford bachelor apprentice and the study's lead author, said in a university talk release.
Showing posts with label stanford. Show all posts
Showing posts with label stanford. Show all posts
Tuesday, 29 November 2011
Saturday, 4 December 2010
Scanning The Human Genome Provide Insights Into The Likelihood Of Future Disease
Scanning The Human Genome Provide Insights Into The Likelihood Of Future Disease.
Stephen Quake, a Stanford University professor of bioengineering, now has a very upstanding sanity of his own genetic destiny. Quake's DNA was the cynosure of the basic wholly mapped genome of a well man aimed at predicting to be to come health risks. The pore over was conducted by a team of Stanford researchers and fetch about $50,000 FitoDerm price. The researchers say they can now augur Quake's risk for dozens of diseases and how he might answer to a number of widely used medicines.
This pattern of individualized risk report could become common within the next decade and may become much cheaper, according to the Stanford team. "The $1000 genome check-up is coming fast. The take exception to lies in wily what to do with all that information. We've focused on establishing priorities that will be most utilitarian when a invalid and a physician are sitting together looking at the computer screen," Euan Ashley, an second professor of medicine, said in a university advice release.
Those priorities embody assessing how a person's bustle levels, weight, diet and other lifestyle habits link with his or her genetic risk for, or shelter against, health problems such as diabetes or mettle attack. It's also important to determine if a unavoidable medication is likely to benefit the patient or cause baleful side effects.
"We're at the dawn of a new seniority in genomics," Quake said. "Information get off on this will enable doctors to deliver personalized healthfulness care like never before. Patients at peril for certain diseases will be able to receive closer monitoring and more persistent testing, while those who are at lower risk will be spared inessential tests. This will have important profitable benefits as well, because it improves the efficiency of medicine".
Stephen Quake, a Stanford University professor of bioengineering, now has a very upstanding sanity of his own genetic destiny. Quake's DNA was the cynosure of the basic wholly mapped genome of a well man aimed at predicting to be to come health risks. The pore over was conducted by a team of Stanford researchers and fetch about $50,000 FitoDerm price. The researchers say they can now augur Quake's risk for dozens of diseases and how he might answer to a number of widely used medicines.
This pattern of individualized risk report could become common within the next decade and may become much cheaper, according to the Stanford team. "The $1000 genome check-up is coming fast. The take exception to lies in wily what to do with all that information. We've focused on establishing priorities that will be most utilitarian when a invalid and a physician are sitting together looking at the computer screen," Euan Ashley, an second professor of medicine, said in a university advice release.
Those priorities embody assessing how a person's bustle levels, weight, diet and other lifestyle habits link with his or her genetic risk for, or shelter against, health problems such as diabetes or mettle attack. It's also important to determine if a unavoidable medication is likely to benefit the patient or cause baleful side effects.
"We're at the dawn of a new seniority in genomics," Quake said. "Information get off on this will enable doctors to deliver personalized healthfulness care like never before. Patients at peril for certain diseases will be able to receive closer monitoring and more persistent testing, while those who are at lower risk will be spared inessential tests. This will have important profitable benefits as well, because it improves the efficiency of medicine".
Subscribe to:
Posts (Atom)